Floatz logo

Cyclophosphamide

Childhood Lymphoma

Actuate Therapeutics Inc.Small moleculePhase 1Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
39/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Childhood Lymphoma cohort.

Asset / SponsorPhaseRating
axp107-11
University of Virginia
Phase 2CCC
Epirubicin
Children's Hospital Medical Center, Cincinnati
Early Phase 1CC
Decitabine
Children's Hospital Medical Center, Cincinnati
Early Phase 1CC
Pembrolizumab
Children's Hospital Medical Center, Cincinnati
Early Phase 1CC

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →